Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) Return on Equity (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Return on Equity data on record, last reported at 3.01% in Q3 2025.

  • For Q3 2025, Return on Equity fell 301.0% year-over-year to 3.01%; the TTM value through Sep 2025 reached 3.01%, down 301.0%, while the annual FY2023 figure was 0.13%, 121.0% up from the prior year.
  • Return on Equity reached 3.01% in Q3 2025 per SNTI's latest filing, down from 1.04% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.43% in Q2 2024 and bottomed at 3.01% in Q3 2025.
  • Average Return on Equity over 5 years is 0.48%, with a median of 0.26% recorded in 2023.
  • Peak YoY movement for Return on Equity: skyrocketed 206bps in 2023, then tumbled -301bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.04% in 2021, then crashed by -1041bps to 0.38% in 2022, then surged by 143bps to 0.16% in 2023, then plummeted by -101bps to 0.0% in 2024, then crashed by -323095bps to 3.01% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 3.01% in Q3 2025, 1.04% in Q2 2025, and 0.5% in Q1 2025.